Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
ID - 453802
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453802/all/Dipeptidyl_peptidase_4__DPP_4__inhibitors_for_type_2_diabetes_mellitus
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -